Home › Funds › GLENVIEW CAPITAL MANAGEMENT, LLC › VTRS
GLENVIEW CAPITAL MANAGEMENT, LLC position in VTRS
VIATRIS INC · Health Care
GLENVIEW CAPITAL MANAGEMENT, LLC reported holding 9,877,409 shares of VTRS (VIATRIS INC) in its Q2 2026 13F filing — a position valued at US$156.9M, representing 3.00% of its reported portfolio and ranking #12 among its reported holdings. GLENVIEW CAPITAL MANAGEMENT, LLC has disclosed VTRS holdings in 11 of the last 11 reported quarters, going back to Q4 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How GLENVIEW CAPITAL MANAGEMENT, LLC's VTRS position evolved
GLENVIEW CAPITAL MANAGEMENT, LLC first disclosed a stake in VTRS in Q4 2023 at 6,065,047 shares (US$65.7M). The position peaked in Q2 2026 at 9,877,409 shares, worth US$156.9M. Across 11 filings, GLENVIEW CAPITAL MANAGEMENT, LLC increased the stake 5 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 9,877,409 shares valued at US$156.9M — an increase of 790,165 shares quarter over quarter.. Notable position changes include a 26% increase in Q2 2024 (shares rose 9% over the following quarter), a 34% increase in Q4 2025 (shares rose 9% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 6.07M | $65.68M | New |
| Q1 2024 | 5.14M | $61.40M | Reduce |
| Q2 2024 | 6.49M | $69.04M | Add |
| Q3 2024 | 7.57M | $87.91M | Add |
| Q4 2024 | 9.32M | $116.08M | Add |
| Q1 2025 | 8.49M | $73.97M | Reduce |
| Q2 2025 | 8.25M | $73.65M | Reduce |
| Q3 2025 | 8.25M | $81.65M | Hold |
| Q4 2025 | 11.09M | $138.04M | Add |
| Q1 2026 | 9.09M | $122.77M | Reduce |
| Q2 2026 | 9.88M | $156.85M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About VTRS and 13F data
VTRS (VIATRIS INC) is a Health Care company. 33 other funds we track also report a position in VTRS — the largest reported positions include DAVIS SELECTED ADVISERS (US$1.19B), Rubric Capital Management LP (US$542.6M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$320.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VTRS
- DAVIS SELECTED ADVISERS 75.23M sh · $1.19B · Q2 2026
- Rubric Capital Management LP 34.17M sh · $542.60M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 20.21M sh · $320.87M · Q2 2026
- Callodine Capital Management, LP 8.00M sh · $127.05M · Q2 2026
More on GLENVIEW CAPITAL MANAGEMENT, LLC
FAQ
How long has GLENVIEW CAPITAL MANAGEMENT, LLC held VTRS?
GLENVIEW CAPITAL MANAGEMENT, LLC has disclosed VTRS holdings in 11 of the last 11 reported quarters, going back to Q4 2023.
What is GLENVIEW CAPITAL MANAGEMENT, LLC's current position in VTRS?
As of Q2 2026, GLENVIEW CAPITAL MANAGEMENT, LLC holds 9.88M shares of VTRS (VIATRIS INC), valued at $156.85M, representing 3.00% of its reported portfolio and ranking #12.
Has GLENVIEW CAPITAL MANAGEMENT, LLC been buying or selling VTRS?
In the latest 13F filing (Q2 2026), GLENVIEW CAPITAL MANAGEMENT, LLC increased its position in VTRS. The position peaked in Q2 2026 at 9.88M shares.
Which other funds hold VTRS?
Other major institutional holders of VTRS include DAVIS SELECTED ADVISERS, Rubric Capital Management LP, DEERFIELD MANAGEMENT COMPANY, L.P., among 33 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.